BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BrainZ Instruments (BZI) Extends Distribution Agreement with GE Healthcare


3/13/2007 4:35:06 PM

13 March 2007: BrainZ Instruments (ASX: BZI) has extended its current distribution agreement with GE Healthcare, one of the world’s largest medical equipment companies.

The current agreement between BrainZ and GE Healthcare covers distribution of the BrainZ product line which is focused around the BRM2 neonatal brain monitor. The agreement has been expanded to include seven new Asian countries including India and Korea. These countries are in addition to the USA, UK, Canada and 34 European and Middle Eastern territories which are covered under the existing contract.

BrainZ and GE Healthcare have also mutually agreed to extend the current agreement for a further 19 months through to October 2008.

“The expansion of the GE agreement into Asian markets will assist in the further globalisation of the BrainZ technology, thereby improving the care of newborn babies’ brains in more centres around the world,” commented BrainZ CEO Dr Justin Vaughan.

“The extension of the agreement through to 2008 allows us to cement in the relationship with GE Healthcare, penetrate new markets, and improve our distribution effectiveness in existing markets. We indicated in December 2006 that US sales had under-performed against our expectations. While the US sales funnel remains significant, and the prospects bright, conversions from the funnel into sales have been below expectations during this financial period, and we are working closely with GE on strategies to improve sales in the US. We both remain convinced of the significant opportunity that exists within this key market.” Dr Vaughan stated.

About BrainZ Instruments Limited:

BrainZ (ASX: BZI) is a New Zealand based medical technology company specializing in the research, development, manufacturing and sale of bedside brain monitoring technology. The BRM2 Brain Monitor, BrainZ’s first product, is a unique bedside tool that assists in the detection of brain injury and seizure activity in neonates. It has been specifically designed to assist intensive care staff with clinical decision-making in conjunction with other clinical data and in the direction of care on a day-to-day basis.

The BRM2 monitor has received regulatory approval and is in use in 16 countries worldwide. BrainZ dominates the local Australian and New Zealand markets via direct sales channels. BRM2 monitors are also installed in over 40 leading US hospitals. BrainZ has secured an exclusive agreement with GE Healthcare, a leading supplier of patient monitoring systems, for the distribution of BRM2 Brain Monitors in the USA and UK markets.

BrainZ Instruments was established in 2001 to commercialize pioneering neonatal brain research from the Auckland University’s Liggins Institute. Originally a subsidiary of NeuronZ Ltd, BrainZ was acquired by Tru-Test Ltd in September 2002. Tru-Test is a multinational company specialising in electronic technology solutions. BrainZ publicly listed on the Australian Stock Exchange (ASX) in December 2005, raising AUD 13 million.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES